Anonymous
Guest
Anonymous
Guest
They will lose money even faster if they spend money on an EU sales force.
Nobody will make it for the EU.
Can the US plants supply Europe?
Will anyone be willing to sell it? What can they offer? can they pay $20K/patient and still make any money? That would be maybe $20M in revenue for the company selling in the first year and the usual low single digit growth until the market saturates like it has in the US. Do big pharmas sneeze for $20M/yr then peaking at maybe $80M before declining?
What would trying to do it alone cost over the next year, I'd guess at least $100M. So, they can't think about doing that unless they want to bankrupt the company.
Nobody will make it for the EU.
Can the US plants supply Europe?
Will anyone be willing to sell it? What can they offer? can they pay $20K/patient and still make any money? That would be maybe $20M in revenue for the company selling in the first year and the usual low single digit growth until the market saturates like it has in the US. Do big pharmas sneeze for $20M/yr then peaking at maybe $80M before declining?
What would trying to do it alone cost over the next year, I'd guess at least $100M. So, they can't think about doing that unless they want to bankrupt the company.